Why the study?
Although the benefits of ADRB1 blockade in cardiovascular disease are established, the in vivo role for cardiomyocyte ADRB1 remains undetermined.
Does cardiomyocyte-specific ADRB1 knockout affect cardiac functional recovery from afterload elevation and heart rate-dependent functional enhancement?
Does cardiomyocyte-specific ADRB1 knockout affect cardiac functional recovery from afterload elevation and heart rate-dependent functional enhancement?
Cardiomyocyte ADRB1 plays a pivotal role in cardiac stress adaptability, providing mechanistic insights relevant to the management of patients on β-blockers.
Although the benefits of β-1 adrenergic receptor (ADRB1) blockade to cardiovascular disease are established, in vivo role for cardiomyocyte ADRB1 remains undetermined. Generating cardiomyocyte-specific ADRB1 knockout mice, we show that ADRB1 is pivotal to cardiac functional recovery from afterload elevation and heart rate-dependent functional enhancement as well as baseline performance. Our findings highlight the importance of cardiomyocyte ADRB1 in cardiac stress adaptability, which is of clinical importance in the management of patients on β-blockers.
No takes yet. Share an insight, caveat, or question.
Numata et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: